Cencora, Inc. (COR)

Market Cap	68.76B
Revenue (ttm)	321.33B
Net Income (ttm)	1.55B
Shares Out	194.53M
EPS (ttm)	7.96
PE Ratio	44.41
Forward PE	20.08
Dividend	$2.40 (0.68%)
Ex-Dividend Date	Nov 14, 2025

Volume	1,137,649
Open	351.43
Previous Close	352.47
Day's Range	347.63 - 353.56
52-Week Range	237.71 - 377.54
Beta	0.66
Analysts	Buy
Price Target	366.29 (+3.62%)
Earnings Date	Feb 4, 2026

About COR

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2001
• Employees: 51,000
• Stock Exchange: NYSE
• Ticker Symbol: COR
• Website: https://www.cencora.com

Financial Performance

In 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Analyst Summary

According to 14 analysts, the average rating for COR stock is "Buy." The 12-month stock price target is $366.29, which is an increase of 3.62% from the latest price.

Price Target

$366.29

(3.62% upside)

Analyst Consensus: Buy